TMEM43 Antibodies

Santa Cruz Biotechnology features a diverse variety of TMEM43 monoclonal antibodies for investigating transmembrane protein 43 function and regulation. Multiple validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TMEM43, also known as transmembrane protein 43, plays essential roles in membrane trafficking and cell signaling pathways. Research has shown TMEM43's involvement in cardiac function and development. Mutations in TMEM43 are associated with arrhythmogenic right ventricular cardiomyopathy, making it a significant focus in cardiovascular research. Understanding TMEM43's molecular mechanisms can reveal new therapeutic approaches for treating heart conditions. Exploring TMEM43's cellular distribution and interactions provides valuable insights into its biological functions. Detailed characterization of TMEM43 expression patterns helps identify its role in both healthy and diseased states. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of TMEM43 and its impact on human health.